NexPoint Capital Concludes Tender Offer for Common Stock

The offer, which allowed for the repurchase of up to 1.0% of the company's outstanding shares, officially closed at 4:00 p.m. Eastern Time on September 22, 2026. Shareholders seeking further clarification regarding the transaction or the company's healthcare-focused investment strategy are directed to the firm's tender agent, LODAS Transfer, LLC, or the official corporate website.

NexPoint Capital operates as a non-traded, publicly registered business development company. While the firm maintains an active alternative investment platform, leadership emphasized that this announcement does not constitute investment advice or a formal recommendation regarding the tender of shares. The company’s forward-looking statements remain subject to market volatility, regulatory shifts, and broader economic conditions common to the financial services sector.